Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: herpes type 1; This case was reported by a physician and described the occurrence of herpes simplex type i in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced herpes simplex type i (serious criteria death). On an unknown date, the outcome of the herpes simplex type i was fatal. The reported cause of death was herpes simplex type i. It was unknown if the reporter considered the herpes simplex type i to be related to Shingrix. Additional case details were reported as follows: The age at vaccination was not reported. The patient died after about 6 months after the 2nd dose of Shingrix and one of the cause was herpes type 1.; Reported Cause(s) of Death: herpes type 1
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166